OTCMKTS:GNMLF

Genomma Lab Internacional 10/21/2026 Earnings Results & Report

$0.85 0.00 (0.00%)
As of 11/13/2026

Genomma Lab Internacional was expected to report earnings on October 21, 2026, after market closes. Analysts expected earnings of $0.0216 per share on revenue of $241.75 million. Confirmed results have not been posted yet. This page will update with the reported figures, conference call transcript, and earnings documents as they become available.

Earnings Announcement Details

Announcement Date
Time
After Market Closes

Genomma Lab Internacional EPS Results

Actual EPS
N/A
Consensus EPS
$0.0216
Beat/Miss
N/A
One Year Ago EPS
N/A

Genomma Lab Internacional Revenue Results

Actual Revenue
N/A
Expected Revenue
$241.75 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Genomma Lab Internacional Earnings Headlines

Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
See More Genomma Lab Internacional Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Genomma Lab Internacional? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genomma Lab Internacional and other key companies, straight to your email.

About Genomma Lab Internacional

Genomma Lab Internacional (OTCMKTS:GNMLF) is a Mexican consumer health and pharmaceutical company that develops, markets and sells over-the-counter medicines and personal care products. Its offerings address needs such as cold and flu relief, pain management, skin care and hair care.

The company’s brands include Asepxia, Cicatricure, Tío Nacho, Goicoechea and XL-3. Products are sold in Mexico and across a range of other markets, particularly in Latin America.

Founded in Mexico in 1996, Genomma Lab built its business around consumer-focused health and beauty products and has expanded its portfolio through product development and brand growth.

View Genomma Lab Internacional Profile